Advances in tenascin-C biology

被引:262
作者
Midwood, Kim S. [1 ]
Hussenet, Thomas [2 ]
Langlois, Benoit [2 ]
Orend, Gertraud [2 ]
机构
[1] Univ Oxford, Kennedy Inst Rheumatol Div, Fac Med, NDORMS, London W6 8LH, England
[2] Univ Strasbourg, Inst Natl Sante & Rech Med, U682, Serv Biol Mol,CHRU Strasbourg,Fac Med,UMR S682, F-67200 Strasbourg, France
关键词
Tenascin-C; Cardiac injury; Vascular imaging; Stem cells; Tumor metastasis; MATRIX-METALLOPROTEINASE ACTIVITY; MUSCLE-CELL-PROLIFERATION; HUMAN BRAIN-TUMORS; EXTRACELLULAR-MATRIX; GENE-EXPRESSION; MESSENGER-RNA; NEOINTIMAL HYPERPLASIA; MYOCARDIAL-INFARCTION; QUANTITATIVE-ANALYSIS; DYNAMIC EXPRESSION;
D O I
10.1007/s00018-011-0783-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Tenascin-C is an extracellular matrix glycoprotein that is specifically and transiently expressed upon tissue injury. Upon tissue damage, tenascin-C plays a multitude of different roles that mediate both inflammatory and fibrotic processes to enable effective tissue repair. In the last decade, emerging evidence has demonstrated a vital role for tenascin-C in cardiac and arterial injury, tumor angiogenesis and metastasis, as well as in modulating stem cell behavior. Here we highlight the molecular mechanisms by which tenascin-C mediates these effects and discuss the implications of mis-regulated tenascin-C expression in driving disease pathology.
引用
收藏
页码:3175 / 3199
页数:25
相关论文
共 199 条
[1]   Glypican-1, phosphacan/receptor protein-tyrosine phosphatase-ζ/β and its ligand, tenascin-C, are expressed by neural stem cells and neural cells derived from embryonic stem cells [J].
Abaskharoun, Mary ;
Bellemare, Marie ;
Lau, Elizabeth ;
Margolis, Richard U. .
ASN NEURO, 2010, 2 (03) :179-187
[2]  
Adams M, 2002, CANCER RES, V62, P3289
[3]   Specific processing of tenascin-C by the metalloprotease meprinβ neutralizes its inhibition of cell spreading [J].
Ambort, Daniel ;
Brellier, Florence ;
Becker-Pauly, Christoph ;
Stoecker, Walter ;
Andrejevic-Blant, Snezana ;
Chiquet, Matthias ;
Sterchi, Erwin E. .
MATRIX BIOLOGY, 2010, 29 (01) :31-42
[4]   Circulating tenascin-C levels in patients with idiopathic dilated cardiomyopathy [J].
Aso, N ;
Tamura, A ;
Nasu, M .
AMERICAN JOURNAL OF CARDIOLOGY, 2004, 94 (11) :1468-1470
[5]  
Atula T, 2003, ANTICANCER RES, V23, P3051
[6]   The angiogenic switch in carcinogenesis [J].
Baeriswyl, Vanessa ;
Christofori, Gerhard .
SEMINARS IN CANCER BIOLOGY, 2009, 19 (05) :329-337
[7]   Vascular tenascin-C regulates cardiac endothelial phenotype and neovascularization [J].
Ballard, Victoria L. T. ;
Sharma, Arti ;
Duignan, Inga ;
Holm, Jacquelyne M. ;
Chin, Andrew ;
Choi, Ruby ;
Hajjar, Katherine A. ;
Wong, Shing-Chiu ;
Edelberg, Jay M. .
FASEB JOURNAL, 2006, 20 (02) :717-+
[8]   APPEARANCE OF THE MYOFIBROBLASTIC PHENOTYPE IN DUPUYTRENS DISEASE IS ASSOCIATED WITH A FIBRONECTIN, LAMININ, COLLAGEN TYPE-IV AND TENASCIN EXTRACELLULAR-MATRIX [J].
BERNDT, A ;
KOSMEHL, H ;
KATENKAMP, D ;
TAUCHMANN, V .
PATHOBIOLOGY, 1994, 62 (02) :55-&
[9]   A comparative analysis of oncofetal fibronectin and tenascin-C incorporation in tumour vessels using human recombinant SIP format antibodies [J].
Berndt, Alexander ;
Koellner, Robert ;
Richter, Petra ;
Franz, Marcus ;
Voigt, Astrid ;
Berndt, Angela ;
Borsi, Laura ;
Giavazzi, RaVaella ;
Neri, Dario ;
Kosmehl, Hartwig .
HISTOCHEMISTRY AND CELL BIOLOGY, 2010, 133 (04) :467-475
[10]   Expression of angiogenesis associated matrix metalloproteinases and extracellular matrix proteins in cerebral vascular malformations [J].
Bicer, Atilla ;
Guclu, Bulent ;
Ozkan, Abdulkadir ;
Kurtkaya, Ozlem ;
Koc, Demet Yalcinkaya ;
Pamir, M. Necmettin ;
Kilic, Turker .
JOURNAL OF CLINICAL NEUROSCIENCE, 2010, 17 (02) :232-236